⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Caregiver-reported Nonseizure Outcomes with Real-world Use of Cannabidiol (CBD) in Tuberous Sclerosis Complex (TSC): Interim Results from the BECOME-TSC Survey (P8-1.010)

Sarah Wilson Mary Kay Koenig Debopam Samanta Darcy A. Krueger Shelly Meitzler Carly Kaye Sherry Danese Timothy B. Saurer Kelly Simontacchi Karthik Rajasekaran

View Full Paper

Ask AI

Bookmark

Share

Abstract

To report preliminary findings on nonseizure behavioral and cognitive outcomes from the BECOME-TSC caregiver survey to assess changes in BEhavior, COgnition, and More with Epidiolex® in TSC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wilson et al. (2024) studied this question.

synapsesocial.com/papers/68e6feb4b6db643587678b52 https://doi.org/10.1212/wnl.0000000000206298

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Caregiver-reported Seizure Outcomes with Real-world Use of Cannabidiol (CBD) in Tuberous Sclerosis Complex (TSC): Interim Results From the BECOME-TSC Survey (P8-1.005)2024
2Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol (CBD) Treatment: 6-Month Intermediate Analysis of the EpiCom Trial (S5.005)Human Clinical Trial · 2026
3Nonseizure- and seizure-related benefits of cannabidiol treatment in the real world: plain language summary of the results from a caregiver survey2024
4Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program2024 · 5 citations
5Long-term Effectiveness of Cannabidiol (CBD) Against Focal Seizures in Tuberous Sclerosis Complex (TSC): Results from the GWPCARE6 Open-label Extension (OLE) Trial (P8-1.001)2024 · 1 citations